Cargando…

Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States

Detalles Bibliográficos
Autores principales:	Iglesias-Lopez, Carolina, Agustí, Antonia, Obach, Mercè, Vallano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261870/ https://www.ncbi.nlm.nih.gov/pubmed/32523535 http://dx.doi.org/10.3389/fphar.2020.00766

Ejemplares similares

Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
por: Iglesias-Lopez, Carolina, et al.
Publicado: (2019)

Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union
por: Iglesias-Lopez, Carolina, et al.
Publicado: (2021)

Current landscape of clinical development and approval of advanced therapies
por: Iglesias-Lopez, Carolina, et al.
Publicado: (2021)

The challenges of access to innovative medicines with limited evidence in the European Union
por: Vallano, Antonio, et al.
Publicado: (2023)

Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States
por: Lee, Mijin, et al.
Publicado: (2023)

Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe
por: Jonker, Carla J., et al.
Publicado: (2022)

Corrigendum: Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications From ESAC-Net and WHO Europe
por: Robertson, Jane, et al.
Publicado: (2021)

Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut)
por: Guarga, Laura, et al.
Publicado: (2019)

Corrigendum: An Ethnobotanical Study of Medicinal Plants in Kinmen
por: Huang, Shyh-Shyun, et al.
Publicado: (2022)

Corrigendum: Monitoring the Spread of Swine Enteric Coronavirus Diseases in the United States in the Absence of a Regulatory Framework
por: Perez, Andres M., et al.
Publicado: (2021)

Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023)

Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023)

Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications
por: Miljković, Nenad, et al.
Publicado: (2020)

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry
por: Owusu-Asante, Mercy, et al.
Publicado: (2023)

Advanced Therapy Medicinal Products for the Eye: Definitions and Regulatory Framework
por: López-Paniagua, Marina, et al.
Publicado: (2021)

Corrigendum: Advances in the study of acetaminophen-induced liver injury
por: Li, Xinghui, et al.
Publicado: (2023)

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future
por: de Bruijn, Winnie, et al.
Publicado: (2016)

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2022)

Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe
por: Vreman, Rick A., et al.
Publicado: (2020)

New pricing models for generic medicines to ensure long-term sustainable competition in Europe
por: Francois, Clement, et al.
Publicado: (2023)

Editorial: Drug development of herbal medicines: Regulatory perspectives
por: Bilia, Anna Rita, et al.
Publicado: (2022)

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
por: Gad, Mohamed, et al.
Publicado: (2020)

Corrigendum: Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
por: Mazzari, Andre L. D. A., et al.
Publicado: (2015)

Corrigendum: The Fruits of Siraitia grosvenorii: A Review of a Chinese Food-Medicine
por: Gong, Xue, et al.
Publicado: (2020)

Corrigendum: Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
por: Guin, Debleena, et al.
Publicado: (2020)

A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe
por: Koomen, Jeroen V., et al.
Publicado: (2021)

Nanomedicines and Nanosimilars—Why a Robust Centralised Regulatory Framework Is Essential to Enhance Patient Safety
por: Isles, Michael P.
Publicado: (2022)

Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2023)

Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
por: Yang, Zhi-Hua, et al.
Publicado: (2021)

Corrigendum: Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2
por: Mirhosseini, Haniye, et al.
Publicado: (2023)

Chinese Herbal Medicine and Its Regulatory Effects on Tumor Related T Cells
por: Hoffman, Robert D., et al.
Publicado: (2020)

Access to medicines for rare diseases: A European regulatory roadmap for academia
por: Rosenberg, Noa, et al.
Publicado: (2023)

Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia
por: Giner-Soriano, Maria, et al.
Publicado: (2023)

Advances in computational frameworks in the fight against TB: The way forward
por: Naidu, Akshayata, et al.
Publicado: (2023)

Corrigendum: A biophoton method for identifying the quality states of fresh Chinese herbs
por: Cao, Baorui, et al.
Publicado: (2023)

Amorpha fruticosa – A Noxious Invasive Alien Plant in Europe or a Medicinal Plant against Metabolic Disease?
por: Kozuharova, Ekaterina, et al.
Publicado: (2017)

Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices
por: Rahalkar, Hasumati, et al.
Publicado: (2021)

Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2022)

Corrigendum: Dosage Modification of Traditional Chinese Medicine Prescriptions: An Analysis of Two Randomized Controlled Trials
por: Zhou, Rongrong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dpops4u8oe15vpqgq8tl77r7ls